Tumor imaging and interferon-g-inducible protein-10 gene transfer using a highly efficient transferrin-conjugated liposome system in mice

Clinical Cancer Research

Volumn 19, Issue 15, 2013, Pages 4206-4217

  Zhuo, Huiqin ^a   Peng, Yi ^b,c   Yao, Qin ^a   Zhou, Nuo ^b,d   Zhou, Sufang ^b   He, Jian ^b   Fang, Yuan ^b   Li, Xi ^b   Jin, Hongwei ^a   Lu, Xiaoling ^b   Zhao, Yongxiang ^b  

^a ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

^c HAINAN MEDICAL UNIVERSITY   (China)

^d Department of Oral and Maxillofacial Surgery   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; LIPOSOME; NANOPARTICLE; PEGYLATED TRANSFERRIN CONJUGATED LIPOSOME; PLASMID DNA; UNCLASSIFIED DRUG; CXCL10 PROTEIN, HUMAN; GAMMA INTERFERON; TRANSFERRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE; BIOPHYSICS; BREAST CANCER; CANCER INHIBITION; CIRCULATION TIME; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FLUORESCENCE; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; IMAGE DISPLAY; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LIPOSOMAL GENE DELIVERY SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR CELL; TUMOR IMAGING; TUMOR TARGETING; ANIMAL; BREAST NEOPLASMS; CHEMISTRY; DRUG SCREENING; GENETICS; HUMAN; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHEMOKINE CXCL10; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; HUMANS; INTERFERON-GAMMA; LIPOSOMES; MICE; TRANSFERRIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84881225603     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-3451     Document Type: Article

References (43)

1. Allen TM. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2002;2:750-63.
2. Namiki Y, Namiki T, Yoshida H, Ishii Y, Tsubota A, Koido S, et al. A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery. Nat Nanotechnol 2009;4:598-606.
3. Kripotin DB,Drummond DC, Shao Y, Shalaby MR, Hong K, Nielsen UB, et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res 2006;66:6732-40.
4. Gao J, Yu Y, Zhang Y, Song J, Chen H, Li W, et al. EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma. Biomaterials 2012;33:270-82.
5. Messerschmidt SK, Kolbe A,Muller D, Knoll M, Pleiss J, Kontermann RE. Novel Single-chain Fv' formats for the generation of immunoliposomes by site-directed coupling. Bioconjug Chem 2008; 19:362-9.
6. Sato Y, Murase K, Kato J, Kobune M, Sato T, Kawano Y, et al. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat Biotechnol 2008;26:431-42.
7. Kang H, O'Donoqhue MB, Liu H, Tan W. A liposome-based nanostructure for aptamer directed delivery. ChemCommun (Camb) 2010;46: 249-51.
8. Bellocq NC, Pun SH, Jensen GS, Davis ME. Transferrin containing, cyclodextrin polymer-based particles for tumour-targeted gene delivery. Bioconjug Chem 2003;14:1122-32.
9. Derycke AS, Kamuhabwa A, Gijsens A, Roskams T, De Vos D, Kasran A, et al. Transferrin-conjugated liposome targeting of photosensitizer AIPcS4 to rat bladder carcinoma cells. J Natl Cancer Inst 2004;96: 1620-30.
10. Maruyama K. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev 2011;63:161-9.
11. Sofou S, Sgouros G. Antibody-targeted liposomes in cancer therapy and imaging. Expert Opin Drug Deliv 2008;5:189-204.
12. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005;4:145-60.
13. Weng KC, Noble CO, Papahadjopoulos-Sternberg B, Chen FF, Drummond DC, Kirpotin DB, et al. Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo. Nano Lett 2008;8:2851-7.
14. Portnoy E, Lecht S, Lazarovici P, Danino D, Maqdassi S. Cetuximablabeled liposomes containing near-infrared probe for in vivo imaging. Nanomedicine 2011;7:480-8.
15. Xiang Y, Liang L, Wang X, Wang J, Zhang X, Zhang Q. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. J Control Release 2011;152:402-10.
16. Keyser J, Schultz J, Ladell K, Elzaouk L, Heinzerling L, Pavlovic J. IP-10-encoding plasmid DNA therapy exhibits anti-tumor and anti-metastatic efficiency. Exp Dermatol 2004;13:380-90.
17. Lu X, Jiang X, Liu R, Zhang S. The enhanced anti-Angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10. Vaccine 2008;26:5352-7.
18. Jiang X, Lu X, Hu P, Liu R. Improved therapeutic efficacy using vaccination with glioma lysate-pulsed dendritic cells combined with IP-10 in murine glioma. Vaccine 2009;27:6210-6.
19. MacDonald RC, MacDonald RI, Menco BP, Takeshita K, Subbarao NK, Hu LR. Small-volume extrusion apparatus for preparation of large, unilamellar vesicles. Biochim Biophys Acta 1991;1061:297-303.
20. Bartlett GR. Phosphorus assay in column chromatography. J Biol Chem 1959;234:466-8.
21. Calzolari A, Oliviero I, Deaglio S, Mariani G, Biffoni M, Maria N, et al. Transferrin receptor 2 is frequently expressed in human cancer cell lines. Blood Cells Mol Dis 2007;39:82-91.
22. Kawamoto M, Horibe T, Kohno M, Kawakami K. A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells. BMC Cancer 2011; 11:359.
23. Obata Y, Saito S, Takeda N, Takeoka S. Plasmid DNA-encapsulating liposomes: Effect of a spacer between the cationic head group and hydrophobic moieties of the lipids on gene expression efficiency. Biochim Biophys Acta 2009;1788:1148-58.
24. Lam AM, Cullis PR. Calcium enhances the transfection potency of plasmid DNA-cationic liposome complexes. Biochim Biophys Acta 2000;1463:279-90.
25. Jeffs LB, Palmer LR, Ambegia EG, Giesbrecht C, Ewanick S, MacLachlan I. A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA. Pharm Res 2005;22:362-72.
26. Bailey AL, Sullivan SM. Efficient encapsulation of DNA plasmids in small neutral liposomes induced by ethanol and calcium. Biochim Biophys Acta 2000;1468:239-52.
27. Xia CF, Boado RJ, Zhang Y, Chu C, Pardridge WM. Intravenous glialderived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter. J Gene Med 2008;10:306-15.
28. Zhang Y, Wang Y, Boado RJ, Pardridge WM. Lysosomal enzyme replacement of the brain with intravenous non-viral gene transfer. Pharm Res 2008;25:400-6.
29. Siwak DR, Tari AM, Lopez-Berestein G. The potential of Drug-carrying immunoliposomes as anticancer agents. Clin Cancer Res 2002;8: 955-6.
30. Sakurai F, Nishioka T, Saito H, Baba T, Okuda A, Matsumoto O, et al. Interaction between DNA-cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid. Gene Ther 2001;8:677-86
31. Mozafari MR, Reed CJ, Rostron C. Serum stability of non-cationic liposomes used for DNA delivery. Micron 2007;38:787-95.
32. Liang GF, Zhu YL, Sun B, Hu FH, Tian T, Li SC, et al. PLGA-based gene delivering nanoparticle enhanced suppression effect of miRNA in HePG2 cells. Nanoscale Res Lett 2011;6:447-56.
33. Li H, Qian ZM. Transferrin/transferrin receptor-mediated drug delivery. Med Res Rev 2002;22:225-50.
34. Singh M, Hawtrey A, Ariatti M. Lipoplexes with biotinylated transferrin accessories: Novel, targeted, serum-tolerant gene carriers. Int J Pharm 2006;321:124-37.
35. Xu S, Liu Y, Tai HC, Zhu J, Ding H, Lee RJ. Synthesis of transferrin (Tf) conjugated liposomes via Staudinger ligation. Int J Pharm 2011;404: 205-10.
36. Tros de Ilarduya C, Duzguneş N. Efficient gene transfer by transferrin lipoplexes in the presence of serum. Biochim Biophys Acta 2000; 1463:333-42
37. Tros de Ilarduya C, Arangoa MA, Moreno-Aliaga MJ, Duzguneş N. Enhanced gene delivery in vitro and in vivo by improved transferrinlipoplexes. Biochim Biophys Acta 2002;1561:209-21.
38. Oliveira AC, Ferraz MP, Monteiro FJ, Simoes S. Cationic liposome-DNA complexes as gene delivery vectors: development and behaviour towards bone-like cells. Acta Biomater 2009;5:2142-51.
39. Iijima H, Negishi Y, Omata D, Nomizu M, Aramaki Y. Cancer cell specific gene delivery by laminin-derived peptide AG73-labeled liposomes. Bioorg Med Chem Lett 2010;20:4712-4.
40. Suzuki R, Takizawa T, Kuwata Y, Mutoh M, Ishiguro N, Utoquchi N, et al. Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome. Int J Pharm 2008;346:143-50.
41. Choi C, Alabi C, Webster P, Davis M. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles. Proc Natl Acad Sci U S A 2010;107:1235-40.
42. Kheirolomoom A, Kruse DE, Qin S, Watson KE, Lai CY, Yong LJ, et al. Enhanced in vivo bioluminescence imaging using liposomal luciferin delivery system. J Control Release 2010;141:128-36.
43. Sato E, Fujimoto J, Toyoki H, Sakaguchi H, Alam SM, Jahan I, et al. Expression of IP-10 related to angiogenesis in uterine cervical cancers. Br J Cancer 2007;96:1735-9.